BenchSci vs Recursion
A side-by-side comparison of BenchSci and Recursion, two Science tools, drawn from Ignaite's continuously-verified listings.
Compared from listings verified as of
At a glance
| Attribute | BenchSci | Recursion |
|---|---|---|
| Category | Science | Science |
| Pricing | PAID | PAID |
| License | Proprietary | Proprietary |
| Deployment | Cloud | Cloud |
| Platforms | Web | Web |
| Model support (differs) | Multi-model | Self-contained (on-device) |
| Vendor (differs) | BenchSci | Recursion Pharmaceuticals |
| Capabilities (differs) |
|
|
The honest brief
BenchSci
Built on a decade-curated Biological Evidence Knowledge Graph of 100M+ papers and figures, not a general LLM bolted onto literature search.
- Grounds answers in curated biomedical evidence
- Reduces unnecessary preclinical experiments
- Integrates a customer's proprietary internal data
- Adopted by top-10 pharma companies
- Enterprise-only; pricing not public
- Narrowly scoped to preclinical R&D
- Requires onboarding with a dedicated team
Recursion
Runs a vast in-house automated wet lab generating millions of cell experiments weekly, feeding a 50+ petabyte dataset few rivals can match.
- Recursion OS with LOWE language layer
- Massive proprietary biology dataset
- Natural-language target and compound queries
- Public company with pharma partners
- No self-serve product or API
- Partner and internal use only
- Opaque pricing
- No approved drug yet
When to pick which
Across the signals we compare, BenchSci and Recursion differ on model support:
- Model support
- Multi-model · Self-contained (on-device)
Their capability lists differ in recorded depth — compare the full lists above before deciding.